Parkinson's disease decisions — 2023

The Veteran's claims for service connection for headaches, sleep apnea, anemia, Parkinson's disease, and neurocognitive disorder have been denied. The evidence does not support a finding of current disabilities or a relationship to service.,There is no evidence of any headache disability during the pendency of the claim or approximate thereto. Sleep apnea was not present in service or within one year after separation from service. Anemia, Parkinson's disease, and neurocognitive disorder did not manifest within one year after separation from service.

The Board has determined that the Veteran is in need of personal care services for a minimum of six continuous months due to his Parkinson's disease, which requires supervision or instruction without which his ability to function would be seriously impaired. The PCAFC eligibility determination must now be reconsidered based on this finding.

The Board has granted entitlement to a TDIU based on the Veteran's service-connected disabilities preventing him from securing and following a substantially gainful occupation. The claim of an initial disability rating in excess of 30 percent for Parkinson's disease is remanded due to a pre-decisional duty to assist error.

The Board has granted service connection for diabetes mellitus, type II, hypertension, and Parkinson's disease from August 10, 2022. The Veteran was presumed to have been exposed to herbicide agents during his service in Guam between April 1966 and October 1967.

The Board has granted service connection for Parkinson's disease and diabetes mellitus, type II (DM II), both presumed due to herbicide exposure in Thailand. Service connection was denied for left lower extremity diabetic neuropathy and right lower extremity diabetic neuropathy.

The Veteran's service-connected disabilities do not meet the eligibility criteria for specially adapted housing or special home adaptation grants due to a lack of permanent and total disability rating.

The Veteran's Parkinson's disease was not shown to be related to service or any presumptive exposure, and the Board denied service connection for this condition.

The Board has decided to remand the case due to insufficient medical opinion regarding the relationship between the Veteran's Parkinson's disease and his toxic exposure during service. The Veteran needs a new opinion that addresses the conflicting medical evidence provided by him.

The Board has granted service connection for PTSD, but dismissed the appeals for degenerative arthritis of the thoracic and lumbar spine and diabetes mellitus. The appeal for Parkinson's disease is remanded to obtain a medical opinion regarding its relationship to service-connected PTSD.

The Board has granted earlier effective dates of May 3, 2021 for the service connection of various Parkinson's disease residuals.,SMC based on housebound criteria was also granted from May 3, 2021.

The Veteran's claim for service connection for Parkinson's disease or essential tremor is being remanded due to the need for additional medical records and a new opinion regarding his essential tremors.

The Board has granted entitlement to TDIU with an effective date of October 13, 2021. The case is being remanded due to a duty-to-assist error in obtaining medical records from Dr. K. and M.Y., FNP.

The Board has remanded the case due to errors in service connection for Parkinson's disease, specifically regarding asbestos exposure and tactical herbicide agents (PACT Act). The AOJ is instructed to verify all periods of service, assess whether the Veteran was involved in a TERA during service, and obtain an adequate medical opinion on the relationship between any identified exposures and the development of Parkinson's disease.

The Board has remanded the claims for chloracne, colon cancer, Parkinson's disease, Hodgkin's lymphoma, left upper extremity peripheral neuropathy (secondary to Hodgkin's lymphoma), right upper extremity peripheral neuropathy (secondary to Hodgkin's lymphoma), left lower extremity peripheral neuropathy (secondary to Hodgkin's lymphoma treatment), and right lower extremity peripheral neuropathy (secondary to Hodgkin's lymphoma treatment).,The Board has also remanded the claim for rhabdomyolysis and AML.

The Veteran's claim for an initial evaluation in excess of 40 percent for right upper extremity tremor and rigidity due to Parkinson's disease prior to January 23, 2020 was denied.,The Veteran's claim for a TDIU since January 23, 2020 is remanded.

The Board has remanded the cases for additional development, including obtaining medical opinions regarding service connection and exposure to herbicides. The Veteran's hearing loss is not compensably rated, and his neurological disorders are being reviewed for possible service connection.

The Board has remanded the claim due to a duty-to-assist error and needs clarification on the Veteran's diagnosis and etiology of his symptoms.

The Veteran's Parkinson's Disease is granted as presumptively related to his in-service exposure to herbicide agents.

The Veteran's Parkinson's disease, coronary artery disease, prostate cancer with removal of prostate surgery residuals, and hypertension are all granted as they were due to herbicide exposure at U-Tapao RTAFB.,The Veteran's skin cancer is denied as there is no evidence linking it to service or herbicide exposure.

The Veteran was granted Level 2 PCAFC benefits prior to February [REDACTED], 2023, due to his inability to self-sustain in the community and need for personal care services.